GlassScriptPhysician profile
Jose Manuel Diaz
NPI 1194721480
$66,540.24
in general payments reported to CMS, 2019-2025
80 companies · $3,183 in 2025
The $3,183 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $7,100 · 2021: $7,481 · 2022: $3,564 · 2023: $3,925 · 2024: $3,425 · 2025: $3,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,367.53 |
| Education | $166.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $23,817.58 | 2019-2023 | |
| Emd Serono, INC. | $15,864.23 | 2019-2025 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $8,021.11 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Ucb, INC. | $1,836.22 | 2019-2025 | Briviact, Rystiggo, Fintepla |
| Abbvie INC. | $1,328.85 | 2021-2025 | Qulipta, Ubrelvy, Duopa |
| Novartis Pharmaceuticals Corporation | $1,226.89 | 2019-2025 | |
| Sk Life Science, INC. | $1,219.61 | 2020-2025 | |
| Genentech USA, INC. | $993.42 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Pfizer INC. | $810.34 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $716.69 | 2021-2025 | Hyqvia, Gammagard |
| Abbott Laboratories | $706.06 | 2019-2025 | Infinity |
| Acadia Pharmaceuticals INC | $677.87 | 2019-2025 | Nuplazid |
| Lilly USA, LLC | $583.64 | 2019-2025 | Emgality, Amyvid, Kisunla |
| Alexion Pharmaceuticals, INC. | $572.95 | 2019-2025 | Ultomiris, Soliris |
| Neurelis, INC. | $439.07 | 2020-2025 | Valtoco |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $409.76 | 2019-2025 | Vumerity, Plegridy, Tysabri |
| Sunovion Pharmaceuticals INC. | $390.08 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $360.25 | 2019-2024 | |
| Boston Scientific Corporation | $328.64 | 2019-2025 | General - Dbs, Vercise |
| Lundbeck LLC | $314.73 | 2020-2025 | Rexulti, Vyepti |
| Eisai INC. | $301.62 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $285.62 | 2020-2025 | Ingrezza, Ongentys |
| Amgen INC. | $269.62 | 2019-2023 | Aimovig |
| Tg Therapeutics, INC. | $259.77 | 2023-2025 | |
| Grifols USA, LLC | $247.36 | 2019-2025 | Gamunex-C |
| Sumitomo Pharma America, INC. | $242.05 | 2023-2024 | Aptiom |
| Supernus Pharmaceuticals, INC. | $207.64 | 2019-2025 | Qelbree |
| Harmony Biosciences LLC | $207.54 | 2020-2023 | Wakix |
| Upsher-Smith Laboratories LLC | $197.25 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $189.81 | 2021-2022 | |
| Argenx US, INC. | $188.59 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Amneal Pharmaceuticals LLC | $162.83 | 2019-2025 | Crexont, Rytary |
| Mallinckrodt Hospital Products INC. | $161.83 | 2020-2021 | |
| Medtronic, INC. | $154.76 | 2021-2025 | Percept PC Brainsense, Activa PC |
| Acorda Therapeutics, INC | $147.56 | 2019-2023 | Ampyra, Inbrija |
| Adamas Pharmaceuticals, INC. | $130.18 | 2019-2021 | |
| Akcea Therapeutics, INC. | $121.83 | 2020 | |
| Celgene Corporation | $120.90 | 2023-2025 | Zeposia |
| Csl Behring | $118.16 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $116.46 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $111.80 | 2021-2025 | Andexxa, Wainua |
| Mallinckrodt Enterprises LLC | $109.64 | 2019 | |
| Kyowa Kirin, INC. | $99.17 | 2019-2021 | |
| Microvention, INC. | $98.13 | 2024 | Azur Cx Detachable, Eric Retrieval Device |
| Idorsia Pharmaceuticals US INC | $95.35 | 2022-2025 | Quviviq, Quviviq |
| Otsuka America Pharmaceutical, INC. | $94.90 | 2024-2025 | Rexulti |
| Arbor Pharmaceuticals, INC. | $89.94 | 2019-2021 | |
| Hospira, INC. | $82.87 | 2024-2025 | |
| Octapharma USA, INC. | $82.87 | 2022 | |
| Axsome Therapeutics, INC. | $77.92 | 2022-2025 | Sunosi |
| Horizon Therapeutics Plc | $72.05 | 2021 | |
| Avanir Pharmaceuticals, INC. | $67.69 | 2019-2020 | |
| Aquestive Therapeutics, INC. | $65.99 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $65.38 | 2021 | |
| Ani Pharmaceuticals, INC. | $63.67 | 2022-2023 | Purified Cortrophin Gel |
| Azurity Pharmaceuticals, INC. | $58.57 | 2024-2025 | Horizant |
| Avion Pharmaceuticals | $57.30 | 2022-2023 | Dhivy |
| Aucta Pharmaceuticals, INC. | $53.52 | 2024 | Motpoly Xr |
| Medtronic USA, INC. | $52.54 | 2019-2020 | |
| Allergan, INC. | $48.44 | 2020 | |
| Ge Healthcare | $48.30 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $46.79 | 2022-2023 | Belbuca |
| Endo Pharmaceuticals INC. | $46.10 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $39.47 | 2020 | |
| Livanova USA, INC. | $38.98 | 2020-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Catalyst Pharmaceuticals, INC. | $37.96 | 2020-2022 | |
| Assertio Therapeutics, INC. | $33.24 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $27.07 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $24.01 | 2023 | Spritam |
| Nevro Corp. | $23.25 | 2022 | |
| Janssen Biotech, INC. | $23.19 | 2025 | |
| Grt US Holding, INC. | $23.11 | 2021 | |
| Corium, LLC | $20.35 | 2022 | |
| Amarin Pharma, INC. | $18.64 | 2020 | |
| Impel Pharmaceuticals INC. | $18.17 | 2023 | Trudhesa |
| Zyla Life Sciences, INC. | $16.48 | 2019 | |
| Insightec,INC | $16.32 | 2023 | Exablate |
| Banner Life Sciences, LLC | $14.19 | 2021 | |
| Promius Pharma LLC | $14.18 | 2019 | |
| Currax Pharmaceuticals LLC | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.